Details of the Drug

General Information of Drug (ID: DMOVXHR)

Drug Name

DYV702

Indication

Disease Entry	ICD 11	Status	REF
Gout	FA25	Phase 2	[1]
------------------------------------------------------------------------------------

Cross-matching ID

References

1	ClinicalTrials.gov (NCT04130204) Randomized, Double-blinded, Placebo-controlled Study of the Efficacy and Safety of DYV700 for Reducing Pain Associated With an Acute Gout Flare. U.S.National Institutes of Health.